KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
62 hedge funds and large institutions have $891M invested in Kinnate Biopharma Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 9 closing their positions.
Holders
62
Holders Change
–
Holders Change %
0%
% of All Funds
1.08%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
9
Increased
17
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$23.7M |
2 |
LGM
2
Logos Global Management
San Francisco,
California
|
$31M |
3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2.94M |
4 |
4
Morgan Stanley
New York
|
$2.03M |
5 |
5
BlackRock
New York
|
$29.6M |